244 related articles for article (PubMed ID: 25806262)
1. Post-operative radiation therapy.
Paumier A; Le Péchoux C
Transl Lung Cancer Res; 2013 Oct; 2(5):423-32. PubMed ID: 25806262
[TBL] [Abstract][Full Text] [Related]
2. Role of adjuvant radiotherapy in completely resected non-small-cell lung cancer.
Péchoux CL; Mercier O; Belemsagha D; Bouaita R; Besse B; Fadel E
EJC Suppl; 2013 Sep; 11(2):123-30. PubMed ID: 26217121
[TBL] [Abstract][Full Text] [Related]
3. Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data.
Le Péchoux C
Oncologist; 2011; 16(5):672-81. PubMed ID: 21378080
[TBL] [Abstract][Full Text] [Related]
4. Post-operative radiation therapy (PORT) in completely resected non-small-cell lung cancer.
Krupitskaya Y; Loo BW
Curr Treat Options Oncol; 2008 Dec; 9(4-6):343-56. PubMed ID: 19387842
[TBL] [Abstract][Full Text] [Related]
5. A narrative review of postoperative adjuvant radiotherapy for non-small cell lung cancer.
Olmetto E; Perna M; Cerbai C; Aquilano M; Banini M; Mariotti M; Livi L; Scotti V
Mediastinum; 2022; 6():4. PubMed ID: 35340837
[TBL] [Abstract][Full Text] [Related]
6. Indications and Parameters Around Postoperative Radiation Therapy for Lung Cancer.
Levy A; Mercier O; Le Péchoux C
J Clin Oncol; 2022 Feb; 40(6):556-566. PubMed ID: 34985927
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
8. Mediastinal radiotherapy after adjuvant chemotherapy for resected non-small cell lung cancer with N2 lymphadenopathy: A novel meta-analysis.
Harling L; Jayakumar S; Ashrafian H; Bille A; Toufektzian L; Smith D
JTCVS Open; 2021 Mar; 5():121-130. PubMed ID: 36003173
[TBL] [Abstract][Full Text] [Related]
9. Postoperative radiotherapy for lung cancer: Is it worth the controversy?
Billiet C; Peeters S; Decaluwé H; Vansteenkiste J; Mebis J; Ruysscher D
Cancer Treat Rev; 2016 Dec; 51():10-18. PubMed ID: 27788387
[TBL] [Abstract][Full Text] [Related]
10. The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.
Feng W; Zhang Q; Fu XL; Cai XW; Zhu ZF; Yang HJ; Xiang JQ; Zhang YW; Chen HQ
BMC Cancer; 2015 May; 15():348. PubMed ID: 25934006
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant therapy of resected non-small-cell lung cancer.
Socinski MA
Clin Lung Cancer; 2004 Nov; 6(3):162-9. PubMed ID: 15555217
[TBL] [Abstract][Full Text] [Related]
12. Association between clinicopathological factors and postoperative radiotherapy in patients with completely resected pathological N2 non-small cell lung cancer.
Xu Y; Li J; Wang J; Hu X; Ma H; Li P; Zheng X; Chen M
Oncol Lett; 2018 Feb; 15(2):2641-2650. PubMed ID: 29434986
[TBL] [Abstract][Full Text] [Related]
13. ACR Appropriateness Criteria® postoperative adjuvant therapy in non-small cell lung cancer.
Decker RH; Langer CJ; Rosenzweig KE; Chang JY; Gewanter RM; Ginsburg ME; Kong FM; Lally BE; Videtic GM; Movsas B
Am J Clin Oncol; 2011 Oct; 34(5):537-44. PubMed ID: 21946673
[TBL] [Abstract][Full Text] [Related]
14. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis.
Kim BH; Kim HJ; Wu HG; Kang CH; Kim YT; Lee SH; Kim DW
Clin Lung Cancer; 2014 Sep; 15(5):356-64. PubMed ID: 24996882
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
Graeter TP; Sebastian B; Bischof M; Kugler G; Fischer JR; Schneider T
Thorac Cardiovasc Surg; 2016 Sep; 64(6):501-6. PubMed ID: 26322832
[TBL] [Abstract][Full Text] [Related]
16. Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy.
Wang W; Men Y; Wang J; Zhou Z; Chen D; Xiao Z; Feng Q; Lv J; Liang J; Bi N; Gao S; Wang L; Hui Z
BMC Cancer; 2019 May; 19(1):478. PubMed ID: 31113432
[TBL] [Abstract][Full Text] [Related]
17. The effect of postoperative radiotherapy on the survival of patients with resectable stage III-N2 non-small-cell lung cancer: a systematic review and meta-analysis.
Zhang H; Zhang DX; Ju T; Zhou J
Neoplasma; 2019 Sep; 66(5):717-726. PubMed ID: 31129967
[TBL] [Abstract][Full Text] [Related]
18. Role of Adjuvant Radiotherapy in Non-Small Cell Lung Cancer-A Review.
Süveg K; Plasswilm L; Iseli T; Leskow P; Fischer GF; Putora PM
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406388
[TBL] [Abstract][Full Text] [Related]
19. The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer.
Yuan C; Tao X; Zheng D; Pan Y; Ye T; Hu H; Xiang J; Zhang Y; Chen H; Sun Y
J Surg Oncol; 2019 Mar; 119(3):379-387. PubMed ID: 30536966
[TBL] [Abstract][Full Text] [Related]
20. Postoperative Radiotherapy for Patients With Resectable Stage III-N2 Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
Lei T; Li J; Zhong H; Zhang H; Jin Y; Wu J; Li L; Xu B; Song Q; Hu Q
Front Oncol; 2021; 11():680615. PubMed ID: 34336667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
